363 related articles for article (PubMed ID: 25990004)
1. The age-risk relationship of hematologic malignancies in patients with rheumatoid arthritis: a nationwide retrospective cohort study.
Lin YC; Chou HW; Tsai WC; Yen JH; Chang SJ; Lin YC
Clin Rheumatol; 2015 Jul; 34(7):1195-202. PubMed ID: 25990004
[TBL] [Abstract][Full Text] [Related]
2. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis and risk of acute myocardial infarction--a nationwide retrospective cohort study.
Chung WS; Lin CL; Peng CL; Chen YF; Lu CC; Sung FC; Kao CH
Int J Cardiol; 2013 Oct; 168(5):4750-4. PubMed ID: 23938220
[TBL] [Abstract][Full Text] [Related]
4. Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis. A nationwide population-based cohort study.
Chuang YW; Yu MC; Lin CL; Yu TM; Shu KH; Huang ST; Kao CH
Thromb Haemost; 2016 Jan; 115(2):439-45. PubMed ID: 26446613
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study.
Shen TC; Lin CL; Chen CH; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC
QJM; 2014 Jul; 107(7):537-43. PubMed ID: 24497528
[TBL] [Abstract][Full Text] [Related]
6. The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.
Cho SK; Lee J; Han M; Bae SC; Sung YK
Arthritis Res Ther; 2017 Dec; 19(1):277. PubMed ID: 29246243
[TBL] [Abstract][Full Text] [Related]
7. Incidence and patterns of malignancies in a multi-ethnic cohort of rheumatoid arthritis patients.
Lim XR; Xiang W; Tan JWL; Koh LW; Lian TY; Leong KP; Koh ET;
Int J Rheum Dis; 2019 Sep; 22(9):1679-1685. PubMed ID: 31297986
[TBL] [Abstract][Full Text] [Related]
8. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
Ann Rheum Dis; 2005 Oct; 64(10):1414-20. PubMed ID: 15843454
[TBL] [Abstract][Full Text] [Related]
9. No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan.
Huang WK; Chiou MJ; Kuo CF; Lin YC; Yu KH; See LC
Rheumatol Int; 2014 Oct; 34(10):1379-86. PubMed ID: 24671499
[TBL] [Abstract][Full Text] [Related]
10. The risk of asthma in rheumatoid arthritis: a population-based cohort study.
Shen TC; Lin CL; Wei CC; Tu CY; Li YF
QJM; 2014 Jun; 107(6):435-42. PubMed ID: 24448376
[TBL] [Abstract][Full Text] [Related]
11. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).
Kauppi M; Pukkala E; Isomäki H
Cancer Causes Control; 1997 Mar; 8(2):201-4. PubMed ID: 9134244
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.
Chung WS; Peng CL; Lin CL; Chang YJ; Chen YF; Chiang JY; Sung FC; Kao CH
Ann Rheum Dis; 2014 Oct; 73(10):1774-80. PubMed ID: 23926057
[TBL] [Abstract][Full Text] [Related]
13. Risk of malignancy among patients with rheumatic conditions.
Thomas E; Brewster DH; Black RJ; Macfarlane GJ
Int J Cancer; 2000 Nov; 88(3):497-502. PubMed ID: 11054684
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of rheumatoid arthritis among patients with Mycoplasma pneumonia: A nationwide population-based cohort study in Taiwan.
Chu KA; Chen W; Hsu CY; Hung YM; Wei JC
PLoS One; 2019; 14(1):e0210750. PubMed ID: 30640923
[TBL] [Abstract][Full Text] [Related]
15. The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis.
Lee H
Yonsei Med J; 2019 Feb; 60(2):223-229. PubMed ID: 30666845
[TBL] [Abstract][Full Text] [Related]
16. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population.
Hashimoto A; Chiba N; Tsuno H; Komiya A; Furukawa H; Matsui T; Nishino J; Tohma S
J Rheumatol; 2015 Apr; 42(4):564-71. PubMed ID: 25593236
[TBL] [Abstract][Full Text] [Related]
17. Reduced Risk of Parkinson Disease in Patients With Rheumatoid Arthritis: A Nationwide Population-Based Study.
Sung YF; Liu FC; Lin CC; Lee JT; Yang FC; Chou YC; Lin CL; Kao CH; Lo HY; Yang TY
Mayo Clin Proc; 2016 Oct; 91(10):1346-1353. PubMed ID: 27712633
[TBL] [Abstract][Full Text] [Related]
18. Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study.
Berghen N; Teuwen LA; Westhovens R; Verschueren P
Clin Rheumatol; 2015 Oct; 34(10):1687-95. PubMed ID: 26219489
[TBL] [Abstract][Full Text] [Related]
19. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Arthritis Rheum; 2010 May; 62(5):1252-8. PubMed ID: 20155827
[TBL] [Abstract][Full Text] [Related]
20. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study.
Buchbinder R; Van Doornum S; Staples M; Lassere M; March L
BMC Musculoskelet Disord; 2015 Oct; 16():309. PubMed ID: 26481039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
